Oftaquix 1.5% Eye Drops

Drop

Reduction of elevated intraocular pressure (IOP) in open-angle glaucoma and ocular hypertension

Tafluprost is a prostaglandin F2α analog that increases uveoscleral outflow of aqueous humor from the eye. This lowers intraocular pressure, helping to protect the optic nerve in glaucoma.

For ophthalmic use only. Instill 1 drop in the affected eye(s) once daily, preferably in the evening, or as directed by an ophthalmologist. Remove contact lenses before use and reinsert after 15 minutes; avoid touching the dropper tip to the eye.

Eye redness (conjunctival hyperemia),eye irritation/burning/stinging,itching,foreign body sensation,blurred vision,increased eyelash growth,eye pain,dry eye,changes in iris/eyelid pigmentation

Use with caution in patients with a history of uveitis/iritis, macular edema (especially aphakic/pseudophakic with torn posterior capsule), or herpetic keratitis. May cause permanent darkening of the iris and pigmentation changes of eyelids; may increase eyelash length/thickness. Do not use if allergic to tafluprost or any component. Use separate eye medicines at least 5 minutes apart. If symptoms worsen or signs of eye infection occur, seek medical advice.

Other ophthalmic prostaglandin analogs (may reduce IOP-lowering effect when used together),concurrent ocular medicines (separate administration by 5–10 minutes); no major systemic interactions expected due to minimal systemic absorption

Store at room temperature as per pack label; protect from light and moisture. Keep bottle tightly closed. Do not freeze. Discard as per label instructions after opening if advised.

Taflotan 0.0015% Eye Drops,Taftan 0.0015% Eye Drops,Tafluprost 0.0015% Eye Drops (generic),Taflu 0.0015% Eye Drops,Taflup 0.0015% Eye Drops